Pharmoza.com - Medical Portal

Fight Against Top Killer, Clogged Arteries, Garners Acclaimed NIH ...

 In experiments on a mouse model of atherosclerosis in collaboration with cardiology engineering researcher  Hanjoong Jo at Emory University School of Medicine .

Atherosclerosis brief description

The old explanation about how cholesterol gunk coats blood vessels like lard is not quite correct, but animal fats are involved in atherosclerosis. Here’s a brief description of how the disease clogs arteries.

Oil and water don’t mix.

So, lipoproteins, which are large collections of particular protein molecules, wrap around lipids, which include  oily fats called triglycerides , to transport them through the bloodstream, which is water-based. Some lipoproteins, like the infamous  low-density lipoproteins (LDLs) , deliver lipids to cells, but HDLs pick them up from cells when it’s time for them to leave and take them to the liver for breakdown, a process called  reverse cholesterol transport .

If there aren’t enough well-functioning HDLs in the bloodstream, reverse cholesterol transport can slow down, and the lipids amass in artery walls behind  endothelial cells, which make up the lining inside of arteries .

Atherosclerosis Hope At Last - Bookshelf


Atherosclerosis, Molecular and Cellular Mechanisms
450 pages
Atherosclerosis, Molecular and Cellular Mechanisms

Consequently, a greater understanding of the mechanisms underlying atherosclerosis is essential for the development of new therapeutic approaches for the treatment of cardiovascular disease. ... hyperlipidemia, oxidative stress, and cell growth and phenotype. Although the full picture is not resolved, this book presents our current understanding of some of the key pieces of the jigsaw, which we hope will help to develop better treatments and survival of patients in the future. We hope ...

Inflammation and Atherosclerosis
634 pages
Inflammation and Atherosclerosis

However, during the last two decades this notion has gained increasing momentum, both in basic research and clinical medicine. The latter is also reflected by progress in diagnostic and therapeutic approaches. The present volume strifes to provide an up-to-date information on this topic with contributions from experts in the field taking into account the progress made in the last few years. We hope that this timely and comprehensive volume will find the interest of basic scientists and ...

Atherosclerosis and Oxidant Stress: A New Perspective
247 pages
Atherosclerosis and Oxidant Stress: A New Perspective

In the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico ( GISSI) Prevention Trial, 11,324 patients with a history of acute MI within the last 3 months were randomized in an open-label design to vitamin E (300mg daily), n-3 polyunsaturated fatty acids (1 g daily), both, or neither over 3.5 years.44 The primary ... The Heart Outcomes Prevention Evaluation (HOPE) study randomized 9,541 participants with CVD or diabetes and at least one other CVD risk factor ...

Atherosclerosis and Cardiovascular Diseases, Proceedings of the Sixth International Meeting on Atherosclerosis and Cardiovascular Diseases held in Bologna, Italy, October 27–29,1986
571 pages
Atherosclerosis and Cardiovascular Diseases, Proceedings of the Sixth International Meeting on Atherosclerosis and Cardiovascular Diseases held in Bologna, Italy, October 27–29,1986

Among the many indications for hope in this field is the Consensus Statement of the European Atherosclerosis Society signed a few months ago in Neaples by 26 experts from 15 European countries. But beyond the boundaries of our own profession, governments and their specialized institutions are increasingly ready to promote prevention. On behalf of the Regional Office for Europe of WHO we collected last year the official statements on CVD prevention from Europe (Table 7).

New Hope for People with Lupus, Your Friendly, Authoritative Guide to the Latest in Traditional and Complementar y Solutions
304 pages
New Hope for People with Lupus, Your Friendly, Authoritative Guide to the Latest in Traditional and Complementar y Solutions

Your Friendly, Authoritative Guide to the Latest in Traditional and Complementar y Solutions Theresa Foy Digeronimo. have an infection until proven otherwise. Treatment of pneumonitis ... Research suggests that lupus patients receiving steroids have a higher risk of developing atherosclerosis, but its evolution is also hastened by high cholesterol levels, SLE inflammation itself, and possibly antiphospholipid antibodies. Thus, optimal control of all of these factors is mandatory?4 ...

Atherosclerosis Hope At Last - News


Giving Thanks for What Most Take for Granted
Not just because it's a new year, but because he has hope. For Knudson, something healthy people take for granted every day, like This condition is known as atherosclerosis. High blood pressure: You can manage your blood pressure. It's sometimes 

Heart of the matter: NMR cardiac prognosis
Heart of the matter: NMR cardiac prognosis that suffer heart failure in the USA each year have non-ischemic cardiomyopathy. This form of heart failure is due to changes other than the relatively common form of heart disease, atherosclerosis, or blocked arteries. approaches to improve

'Calcium in arteries is key indicator'
'Calcium in arteries is key indicator' The study used data from almost 7 000 participants in the Multi-Ethnic Study of Atherosclerosis (MESA), who were given risk scores according to the traditional medical factors. They were also given a coronary calcium scan and a CAC score. The MESA 

Top Cardiology Innovations of 2013
to 1 year after treatment in people who cannot undergo an open heart surgery. These findings provide great hope to those patients who are not surgical candidates. In a trial of 947 patients with poorly controlled high blood pressure with

Researcher sees new hope in Alzheimer's treatment
But if you take someone with a lot of atherosclerosis and previous heart attacks and try to lower cholesterol, nothing is going to happen because the damage has already been done. It's the same thing with Alzheimer's. Q: How safe is this antibody to